Two Sigma Investments’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,481
Closed -$1.91M 4598
2025
Q4
$1.91M Hold
46,481
﹤0.01% 2467
2025
Q3
$1.73M Buy
46,481
+11,371
+32% +$413K ﹤0.01% 2223
2025
Q2
$1.28M Buy
+35,110
New +$1.27M ﹤0.01% 2109
2024
Q4
Sell
-6,189
Closed -$260K 3224
2024
Q3
$260K Sell
6,189
-11,222
-64% -$466K ﹤0.01% 2732
2024
Q2
$711K Buy
+17,411
New +$693K ﹤0.01% 2184

Other funds holding BME

Two Sigma Investments's BME Position: Q1 2026 in Review

Two Sigma Investments sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 46,481 shares — an estimated $1.91M sold.

Two Sigma Investments first reported a position in BME in Q2 2024 and held it in 5 quarters. The position peaked at $1.91M in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Two Sigma Investments reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 46,481 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $1.91M.
  • Two Sigma Investments first reported a position in BlackRock Health Sciences Trust in Q2 2024 and held it in 5 quarters.
  • Two Sigma Investments's BlackRock Health Sciences Trust position peaked at $1.91M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.